September 8, 2026

Former Bristol Myers Squibb senior executive brings more than 35 years of global pricing, market access and commercialization experience to Numerof clients

Numerof & Associates, a healthcare strategy consulting firm advising organizations across the life sciences ecosystem, today announced that Laurent Carter, former BMS market access senior executive, has joined the firm as a Senior Consultant and Client Engagement Manager. The partnership expands Numerof’s ability to help biopharma and healthcare organizations respond to mounting policy, pricing, reimbursement, evidence and market access pressures.

Carter will collaborate with Numerof’s senior advisory team to support clients in evaluating market and policy dynamics, strengthening pricing and access strategies, developing compelling clinical and economic value propositions, improving payer and stakeholder engagement, and translating strategy into practical plans for commercialization and growth.

“Laurent has spent his career addressing many of the most consequential market access and commercialization challenges facing biopharma leaders,” said Rita E. Numerof, PhD, President and co-founder of Numerof & Associates. “His experience and judgment significantly strengthen our ability to help clients anticipate change, make difficult strategic choices and connect innovation with sustainable market success.”

Carter brings more than 35 years of biopharma leadership experience spanning global pricing, market access, reimbursement, commercialization, launch strategy, payer engagement and enterprise transformation. Most recently, he served as Senior Vice President and Head of Global Pricing at Bristol Myers Squibb, where he led global pricing strategy and helped shape the company’s approach to value, access and healthcare analytics.

Over the course of his career, Carter has held leadership roles across sales, brand marketing, strategic planning, market access and pricing. His experience spans oncology, cardiology, immunology, nephrology and other therapeutic areas, and includes involvement in more than 24 blockbuster product launches.

“I am very excited to join forces with Numerof & Associates, bringing our complementary expertise and experience together to help organizations navigate an ever-evolving healthcare ecosystem,” said Carter. “At a time of unprecedented change, I look forward to working with the Numerof team to help clients achieve sustainable success while improving outcomes for patients.”

The partnership brings together Carter’s extensive industry leadership with Numerof’s expertise in strategy development and execution, business model design, commercialization and launch planning, payer and health technology assessment analysis, clinical and economic value creation, organizational transformation, research and analytics, and operational improvement.

Carter is the President and Principal of LGC Strategic Consulting, LLC. He earned his undergraduate degree from Brown University and his MBA from the UCLA Anderson School of Management.

About Numerof & Associates
Numerof & Associates is a strategy consulting firm that develops customized, market-based solutions for the strategic and operational challenges of organizations in industries undergoing significant transition. Working globally across the healthcare industry with clients in pharmaceuticals, medical devices and diagnostics, payers, and healthcare delivery, Numerof brings a unique cross-disciplinary approach to a broad range of engagements designed to sharpen strategic focus, increase revenues, reduce costs and risk, and enhance customer value.

Visit nai-consulting.com and connect with us on LinkedIn and X.

Media Contact:
Jamie Shearer
Senior Account Executive, Pinkston
571.405.1606
numerof@pinkston.co